James Hardman Rubright, MD - Medicare Hand Surgery in Nashville, TN

James Hardman Rubright, MD is a medicare enrolled "Orthopaedic Surgery - Hand Surgery" physician in Nashville, Tennessee. He went to University Of North Carolina At Chapel Hill School Of Medicine and graduated in 2007 and has 17 years of diverse experience with area of expertise as Hand Surgery. He is a member of the group practice Tennessee Orthopaedic Alliance Pa and his current practice location is 345 23rd Ave N, Suite 212, Nashville, Tennessee. You can reach out to his office (for appointments etc.) via phone at (615) 963-9200.

James Hardman Rubright is licensed to practice in Tennessee (license number 50561) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1003031261.

Contact Information

James Hardman Rubright, MD
345 23rd Ave N, Suite 212,
Nashville, TN 37203-1513
(615) 963-9200
(615) 963-9201



Physician's Profile

Full NameJames Hardman Rubright
GenderMale
SpecialityHand Surgery
Experience17 Years
Location345 23rd Ave N, Nashville, Tennessee
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • James Hardman Rubright attended and graduated from University Of North Carolina At Chapel Hill School Of Medicine in 2007
  NPI Data:
  • NPI Number: 1003031261
  • Provider Enumeration Date: 04/14/2007
  • Last Update Date: 10/13/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 4789819137
  • Enrollment ID: I20131021001438

Medical Identifiers

Medical identifiers for James Hardman Rubright such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1003031261NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207XS0106XOrthopaedic Surgery - Hand Surgery 50561 (Tennessee)Primary
207X00000XOrthopaedic Surgery 50561 (Tennessee)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Tristar Centennial Medical CenterNashville, TNHospital
Cookeville Regional Medical CenterCookeville, TNHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Tennessee Orthopaedic Alliance Pa5193625069308

News Archive

SequelMed Patient Portal launched by Sequel Systems

Sequel Systems, Inc., a dynamic, service-oriented healthcare technology company, today announced the launch and general availability of SequelMed Patient Portal™, a new, Web-based tool that improves and speeds up communication between physicians and patients, giving patients instant access to their personal health information, and allowing physicians and other healthcare providers more time to focus on delivering the best possible care. SequelMed Patient Portal is the latest addition to Sequel Systems' suite of healthcare solutions, which includes an electronic health record (EHR), practice and document management software, and e-prescribing technology. More than 12,000 physicians in all 50 states and representing all major specialties currently use the company's solutions.

Selective use of biomarker testing for breast cancer patients can save millions of dollars in health care spending

A review of medical records for almost 200 patients with breast cancer suggests that more selective use of biomarker testing for such patients has the potential to save millions of dollars in health care spending without compromising care, according to Johns Hopkins researchers.

Study may pave way for potential drug targets in lung cancer treatment

Researchers from Boston University School of Medicine (BUSM) and the Boston University Biomedical Engineering Department have identified a number of proteins whose activation allows them to distinguish between cancer and normal cells with almost 97 percent accuracy.

New research suggests fasting not required before cholesterol, triglyceride measurement

New research from Denmark, Canada and the US involving more than 300,000 individuals suggests that patients do not need to check their cholesterol levels on an empty stomach. So far fasting has been required before cholesterol and triglyceride measurement in all countries except Denmark, where non-fasting blood sampling has been used since 2009.

Amorfix introduces high affinity antibodies against cancer primary cells

Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced that together with its partner Epitomics, high affinity antibodies to prion protein disease specific epitopes (DSEs) have been produced, which bind preferentially to several cancer primary cells and tumor cell lines, but not normal cells.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. James Hardman Rubright allows following entities to bill medicare on his behalf.
Entity NameTennessee Orthopaedic Alliance Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1538153937
PECOS PAC ID: 5193625069
Enrollment ID: O20040109000069

News Archive

SequelMed Patient Portal launched by Sequel Systems

Sequel Systems, Inc., a dynamic, service-oriented healthcare technology company, today announced the launch and general availability of SequelMed Patient Portal™, a new, Web-based tool that improves and speeds up communication between physicians and patients, giving patients instant access to their personal health information, and allowing physicians and other healthcare providers more time to focus on delivering the best possible care. SequelMed Patient Portal is the latest addition to Sequel Systems' suite of healthcare solutions, which includes an electronic health record (EHR), practice and document management software, and e-prescribing technology. More than 12,000 physicians in all 50 states and representing all major specialties currently use the company's solutions.

Selective use of biomarker testing for breast cancer patients can save millions of dollars in health care spending

A review of medical records for almost 200 patients with breast cancer suggests that more selective use of biomarker testing for such patients has the potential to save millions of dollars in health care spending without compromising care, according to Johns Hopkins researchers.

Study may pave way for potential drug targets in lung cancer treatment

Researchers from Boston University School of Medicine (BUSM) and the Boston University Biomedical Engineering Department have identified a number of proteins whose activation allows them to distinguish between cancer and normal cells with almost 97 percent accuracy.

New research suggests fasting not required before cholesterol, triglyceride measurement

New research from Denmark, Canada and the US involving more than 300,000 individuals suggests that patients do not need to check their cholesterol levels on an empty stomach. So far fasting has been required before cholesterol and triglyceride measurement in all countries except Denmark, where non-fasting blood sampling has been used since 2009.

Amorfix introduces high affinity antibodies against cancer primary cells

Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced that together with its partner Epitomics, high affinity antibodies to prion protein disease specific epitopes (DSEs) have been produced, which bind preferentially to several cancer primary cells and tumor cell lines, but not normal cells.

Read more Medical News

› Verified 5 days ago

Entity NameSelect Health Of Sc, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1962904946
PECOS PAC ID: 7416212972
Enrollment ID: O20210623003548

News Archive

SequelMed Patient Portal launched by Sequel Systems

Sequel Systems, Inc., a dynamic, service-oriented healthcare technology company, today announced the launch and general availability of SequelMed Patient Portal™, a new, Web-based tool that improves and speeds up communication between physicians and patients, giving patients instant access to their personal health information, and allowing physicians and other healthcare providers more time to focus on delivering the best possible care. SequelMed Patient Portal is the latest addition to Sequel Systems' suite of healthcare solutions, which includes an electronic health record (EHR), practice and document management software, and e-prescribing technology. More than 12,000 physicians in all 50 states and representing all major specialties currently use the company's solutions.

Selective use of biomarker testing for breast cancer patients can save millions of dollars in health care spending

A review of medical records for almost 200 patients with breast cancer suggests that more selective use of biomarker testing for such patients has the potential to save millions of dollars in health care spending without compromising care, according to Johns Hopkins researchers.

Study may pave way for potential drug targets in lung cancer treatment

Researchers from Boston University School of Medicine (BUSM) and the Boston University Biomedical Engineering Department have identified a number of proteins whose activation allows them to distinguish between cancer and normal cells with almost 97 percent accuracy.

New research suggests fasting not required before cholesterol, triglyceride measurement

New research from Denmark, Canada and the US involving more than 300,000 individuals suggests that patients do not need to check their cholesterol levels on an empty stomach. So far fasting has been required before cholesterol and triglyceride measurement in all countries except Denmark, where non-fasting blood sampling has been used since 2009.

Amorfix introduces high affinity antibodies against cancer primary cells

Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced that together with its partner Epitomics, high affinity antibodies to prion protein disease specific epitopes (DSEs) have been produced, which bind preferentially to several cancer primary cells and tumor cell lines, but not normal cells.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. James Hardman Rubright is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
James Hardman Rubright, MD
Po Box 306556,
Nashville, TN 37230-6556

Ph: (865) 243-8153
James Hardman Rubright, MD
345 23rd Ave N, Suite 212,
Nashville, TN 37203-1513

Ph: (615) 963-9200

News Archive

SequelMed Patient Portal launched by Sequel Systems

Sequel Systems, Inc., a dynamic, service-oriented healthcare technology company, today announced the launch and general availability of SequelMed Patient Portal™, a new, Web-based tool that improves and speeds up communication between physicians and patients, giving patients instant access to their personal health information, and allowing physicians and other healthcare providers more time to focus on delivering the best possible care. SequelMed Patient Portal is the latest addition to Sequel Systems' suite of healthcare solutions, which includes an electronic health record (EHR), practice and document management software, and e-prescribing technology. More than 12,000 physicians in all 50 states and representing all major specialties currently use the company's solutions.

Selective use of biomarker testing for breast cancer patients can save millions of dollars in health care spending

A review of medical records for almost 200 patients with breast cancer suggests that more selective use of biomarker testing for such patients has the potential to save millions of dollars in health care spending without compromising care, according to Johns Hopkins researchers.

Study may pave way for potential drug targets in lung cancer treatment

Researchers from Boston University School of Medicine (BUSM) and the Boston University Biomedical Engineering Department have identified a number of proteins whose activation allows them to distinguish between cancer and normal cells with almost 97 percent accuracy.

New research suggests fasting not required before cholesterol, triglyceride measurement

New research from Denmark, Canada and the US involving more than 300,000 individuals suggests that patients do not need to check their cholesterol levels on an empty stomach. So far fasting has been required before cholesterol and triglyceride measurement in all countries except Denmark, where non-fasting blood sampling has been used since 2009.

Amorfix introduces high affinity antibodies against cancer primary cells

Amorfix Life Sciences, a product development company focused on diagnostics and therapeutics for misfolded protein diseases, today announced that together with its partner Epitomics, high affinity antibodies to prion protein disease specific epitopes (DSEs) have been produced, which bind preferentially to several cancer primary cells and tumor cell lines, but not normal cells.

Read more News

› Verified 5 days ago


Orthopaedic Surgery Doctors in Nashville, TN

Dr. Robert Joel Otto, M.D.
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 2400 Patterson St Ste 100, Nashville, TN 37203
Phone: 615-342-0038    
Alexander David Savage,
Orthopedic Surgery
Medicare: Medicare Enrolled
Practice Location: 2400 Patterson St Ste 100, Nashville, TN 37203
Phone: 615-342-0038    
William Edward Carpenter, M.D.
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 8 City Blvd Ste 300, Nashville, TN 37209
Phone: 615-823-8891    Fax: 615-321-6226
Daniel Nuri Kiridly, M.D.
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 3443 Dickerson Pike Ste 190, Nashville, TN 37207
Phone: 615-860-1580    
Dr. Chelsea Brown, M.D.
Orthopedic Surgery
Medicare: Medicare Enrolled
Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232
Phone: 615-322-5000    
Dr. Jane Merideth Siegel, MD
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 301 21st Ave N, Nashville, TN 37203
Phone: 615-329-6600    Fax: 615-695-1483

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.